# Primary Antibiotic Prophylaxis Using Co-trimoxazole to Prevent Spontaneous Bacterial Peritonitis in Cirrhosis

> **NCT04395365** · PHASE3 · UNKNOWN · sponsor: **University College, London** · enrollment: 442 (actual)

## Conditions studied

- Spontaneous Bacterial Peritonitis

## Interventions

- **DRUG:** Co-Trimoxazole 960Mg Dispersible Tablet
- **DRUG:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT04395365
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-06-30
- **Primary completion:** 2025-10
- **Final completion:** 2025-10
- **Target enrollment:** 442 (ACTUAL)
- **Last updated:** 2023-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04395365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04395365, "Primary Antibiotic Prophylaxis Using Co-trimoxazole to Prevent Spontaneous Bacterial Peritonitis in Cirrhosis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04395365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*